{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T12:39:31Z","timestamp":1774701571664,"version":"3.50.1"},"reference-count":49,"publisher":"American Society of Hematology","issue":"11","license":[{"start":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T00:00:00Z","timestamp":1712534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,6,11]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>New analytical techniques can assess hundreds of proteins simultaneously with high sensitivity, facilitating the observation of their complex interplay and role in disease mechanisms. We hypothesized that proteomic profiling targeting proteins involved in thrombus formation, inflammation, and the immune response would identify potentially new biomarkers for heparin-induced thrombocytopenia (HIT). Four existing panels of the Olink proximity extension assay covering 356 proteins involved in thrombus formation, inflammation, and immune response were applied to randomly selected patients with suspected HIT (confirmed HIT, n\u00a0= 32; HIT ruled out, n\u00a0= 38; and positive heparin\/platelet factor 4 [H\/PF4] antibodies, n\u00a0= 28). The relative difference in protein concentration was analyzed using a linear regression model adjusted for sex and age. To confirm the test results, soluble P-selectin was determined using enzyme-linked immunosorbent assay (ELISA) in above mentioned patients and an additional second data set (n\u00a0= 49). HIT was defined as a positive heparin-induced platelet activation assay (washed platelet assay). Among 98 patients of the primary data set, the median 4Ts score was 5 in patients with HIT, 4 in patients with positive H\/PF4 antibodies, and 3 in patients without HIT. The median optical density of a polyspecific H\/PF4 ELISA were 3.0, 0.9, and 0.3. Soluble P-selectin remained statistically significant after multiple test adjustments. The area under the receiver operating characteristic curve was 0.81 for Olink and 0.8 for ELISA. Future studies shall assess the diagnostic and prognostic value of soluble P-selectin in the management of HIT.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/bloodadvances.2024012782","type":"journal-article","created":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T20:11:06Z","timestamp":1712607066000},"page":"2825-2834","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":11,"title":["Proteomic profiling for biomarker discovery in heparin-induced thrombocytopenia"],"prefix":"10.1182","volume":"8","author":[{"given":"Henning","family":"Nilius","sequence":"first","affiliation":[{"name":"1Department of Clinical Chemistry, Inselspital University Hospital Bern, Bern, Switzerland"},{"name":"2Graduate School for Health Sciences, University of Bern, Bern, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1462-3893","authenticated-orcid":false,"given":"Hind","family":"Hamzeh-Cognasse","sequence":"additional","affiliation":[{"name":"3French Blood Establishment Auvergne-Rhone-Alpes, Saint-Etienne, France"},{"name":"4University Jean Monnet, Mines Saint-Etienne, INSERM, U 1059 SAINBIOSE, Saint-Etienne, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3469-4923","authenticated-orcid":false,"given":"Janna","family":"Hastings","sequence":"additional","affiliation":[{"name":"5Institute for Implementation Science in Health Care, Faculty of Medicine, University of Zurich, Zurich, Switzerland"},{"name":"6School of Medicine, University of St. Gallen, St. Gallen, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan-Dirk","family":"Studt","sequence":"additional","affiliation":[{"name":"7Division of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3135-4630","authenticated-orcid":false,"given":"Dimitrios A.","family":"Tsakiris","sequence":"additional","affiliation":[{"name":"8Diagnostic Hematology, Basel University Hospital, Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8343-7336","authenticated-orcid":false,"given":"Andreas","family":"Greinacher","sequence":"additional","affiliation":[{"name":"9Institut f\u00fcr Immunologie und Transfusionsmedizin, Universit\u00e4tsmedizin Greifswald, Greifswald, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Mendez","sequence":"additional","affiliation":[{"name":"10Department of Laboratory Medicine, Kantonsspital Aarau, Aarau, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3414-8508","authenticated-orcid":false,"given":"Adrian","family":"Schmidt","sequence":"additional","affiliation":[{"name":"11Institute of Laboratory Medicine and Clinic of Medical Oncology and Hematology, Municipal Hospital Zurich Triemli, Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter A.","family":"Wuillemin","sequence":"additional","affiliation":[{"name":"12Division of Hematology and Central Hematology Laboratory, Cantonal Hospital of Lucerne and University of Bern, Lucerne, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"Gerber","sequence":"additional","affiliation":[{"name":"13Clinic of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prakash","family":"Vishnu","sequence":"additional","affiliation":[{"name":"14Division of Hematology, Fred Hutchinson Cancer Center, University of Washington, Seattle, WA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5556-4351","authenticated-orcid":false,"given":"Lukas","family":"Graf","sequence":"additional","affiliation":[{"name":"15Cantonal Hospital of St. Gallen, Center for Laboratory Medicine, St. Gallen, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1300-7135","authenticated-orcid":false,"given":"Johanna A.","family":"Kremer Hovinga","sequence":"additional","affiliation":[{"name":"16Department of Hematology and Central Hematology Laboratory, Inselspital Bern University Hospital, Bern, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamam","family":"Bakchoul","sequence":"additional","affiliation":[{"name":"17Centre for Clinical Transfusion Medicine, University Hospital of T\u00fcbingen, T\u00fcbingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8041-928X","authenticated-orcid":false,"given":"Fabrice","family":"Cognasse","sequence":"additional","affiliation":[{"name":"3French Blood Establishment Auvergne-Rhone-Alpes, Saint-Etienne, France"},{"name":"4University Jean Monnet, Mines Saint-Etienne, INSERM, U 1059 SAINBIOSE, Saint-Etienne, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4319-2367","authenticated-orcid":false,"given":"Michael","family":"Nagler","sequence":"additional","affiliation":[{"name":"1Department of Clinical Chemistry, Inselspital University Hospital Bern, Bern, Switzerland"},{"name":"18Faculty of Medicine, University of Bern, Bern, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2024,5,31]]},"reference":[{"issue":"3","key":"2024061013552579200_bib1","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMcp1411910","article-title":"Clinical practice. Heparin-induced thrombocytopenia","volume":"373","author":"Greinacher","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"2024061013552579200_bib2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.trsl.2020.04.014","article-title":"Pathogenesis of heparin-induced thrombocytopenia","volume":"225","author":"Arepally","year":"2020","journal-title":"Transl Res"},{"issue":"7","key":"2024061013552579200_bib3","first-page":"2212","article-title":"Pathophysiology and diagnosis of drug-induced immune thrombocytopenia","volume":"9","author":"Vayne","year":"2020","journal-title":"J\u00a0Clin Med"},{"issue":"suppl 1","key":"2024061013552579200_bib4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/ijlh.13223","article-title":"Evolving concepts of pathogenesis of heparin-induced thrombocytopenia: diagnostic and therapeutic implications","volume":"42","author":"Chong","year":"2020","journal-title":"Int J Lab Hematol"},{"issue":"4","key":"2024061013552579200_bib5","first-page":"683","article-title":"Heparin-induced thrombocytopenia: a review of new concepts in pathogenesis, diagnosis, and management","volume":"10","author":"Marchetti","year":"2021","journal-title":"J\u00a0Clin Med"},{"issue":"8","key":"2024061013552579200_bib6","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/ajh.24759","article-title":"Clinical outcomes in a cohort of patients with heparin-induced thrombocytopenia","volume":"92","author":"Kuter","year":"2017","journal-title":"Am J Hematol"},{"issue":"6","key":"2024061013552579200_bib7","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/bjh.18120","article-title":"Managing argatroban in heparin-induced thrombocytopenia: a retrospective analysis of 729 treatment days in 32 patients with confirmed heparin-induced thrombocytopenia","volume":"197","author":"Marchetti","year":"2022","journal-title":"Br J Haematol"},{"issue":"6","key":"2024061013552579200_bib8","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/bjh.18153","article-title":"How to dose and monitor argatroban for treatment of HIT","volume":"197","author":"Warkentin","year":"2022","journal-title":"Br J Haematol"},{"issue":"7","key":"2024061013552579200_bib9","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/ajh.26194","article-title":"Comparative effectiveness and safety of anticoagulants for the treatment of heparin-induced thrombocytopenia","volume":"96","author":"Nilius","year":"2021","journal-title":"Am J Hematol"},{"issue":"5","key":"2024061013552579200_bib10","doi-asserted-by":"crossref","first-page":"e220","DOI":"10.1016\/S2352-3026(18)30046-2","article-title":"Disease burden, complication rates, and health-care costs of heparin-induced thrombocytopenia in the USA: a population-based study","volume":"5","author":"Dhakal","year":"2018","journal-title":"Lancet Haematol"},{"key":"2024061013552579200_bib11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.thromres.2019.11.004","article-title":"Accuracy of heparin-induced platelet aggregation test for the diagnosis of heparin-induced thrombocytopenia","volume":"185","author":"Brodard","year":"2020","journal-title":"Thromb Res"},{"issue":"5","key":"2024061013552579200_bib12","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1046\/j.1537-2995.1994.34594249047.x","article-title":"Laboratory diagnosis of heparin-associated thrombocytopenia and comparison of platelet aggregation test, heparin-induced platelet activation test, and platelet factor 4\/heparin enzyme-linked immunosorbent assay","volume":"34","author":"Greinacher","year":"1994","journal-title":"Transfusion"},{"issue":"5","key":"2024061013552579200_bib13","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1182\/blood-2015-07-661215","article-title":"Diagnostic value of immunoassays for heparin-induced thrombocytopenia: a systematic review and meta-analysis","volume":"127","author":"Nagler","year":"2016","journal-title":"Blood"},{"issue":"14","key":"2024061013552579200_bib14","first-page":"1171","article-title":"Rapid and accurate Bayesian diagnosis of heparin-induced thrombocytopenia","volume":"135","author":"Marchetti","year":"2020","journal-title":"Blood"},{"issue":"8","key":"2024061013552579200_bib15","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1111\/jth.13758","article-title":"Clinical effectiveness of a Bayesian algorithm for the diagnosis and management of heparin-induced thrombocytopenia","volume":"15","author":"Raschke","year":"2017","journal-title":"J\u00a0Thromb Haemost"},{"key":"2024061013552579200_bib16","doi-asserted-by":"crossref","first-page":"101745","DOI":"10.1016\/j.eclinm.2022.101745","article-title":"A\u00a0machine-learning model for reducing misdiagnosis in heparin-induced thrombocytopenia: a prospective, multicenter, observational study","volume":"55","author":"Nilius","year":"2023","journal-title":"eClinicalMedicine"},{"issue":"6","key":"2024061013552579200_bib17","doi-asserted-by":"crossref","first-page":"e0178289","DOI":"10.1371\/journal.pone.0178289","article-title":"Rapid immunoassays for diagnosis of heparin-induced thrombocytopenia: comparison of diagnostic accuracy, reproducibility, and costs in clinical practice","volume":"12","author":"Bankova","year":"2017","journal-title":"PLoS One"},{"key":"2024061013552579200_bib18","doi-asserted-by":"crossref","first-page":"812830","DOI":"10.3389\/fphar.2021.812830","article-title":"Elucidation of cellular contributions to heparin-induced thrombocytopenia using omic approaches","volume":"12","author":"Giles","year":"2021","journal-title":"Front Pharmacol"},{"issue":"6928","key":"2024061013552579200_bib19","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature01514","article-title":"Disease proteomics","volume":"422","author":"Hanash","year":"2003","journal-title":"Nature"},{"key":"2024061013552579200_bib20","volume-title":"Vascular Proteomics: Methods and Protocols","year":"2013"},{"key":"2024061013552579200_bib21","doi-asserted-by":"crossref","first-page":"889647","DOI":"10.3389\/fneur.2022.889647","article-title":"Technical performance evaluation of olink proximity extension assay for blood-based biomarker discovery in longitudinal studies of Alzheimer\u2019s disease","volume":"13","author":"Carlyle","year":"2022","journal-title":"Front Neurol"},{"issue":"6508","key":"2024061013552579200_bib22","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1126\/science.abc6261","article-title":"Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans","volume":"369","author":"Arunachalam","year":"2020","journal-title":"Science"},{"issue":"10256","key":"2024061013552579200_bib23","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/S0140-6736(20)31964-4","article-title":"Plasma ACE2 and risk of death or cardiometabolic diseases: a case-cohort analysis","volume":"396","author":"Narula","year":"2020","journal-title":"Lancet"},{"issue":"2","key":"2024061013552579200_bib24","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/s41591-020-01211-7","article-title":"Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage III melanoma","volume":"27","author":"Rozeman","year":"2021","journal-title":"Nat Med"},{"issue":"1","key":"2024061013552579200_bib25","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1038\/s41467-021-22767-z","article-title":"Next generation plasma proteome profiling to monitor health and disease","volume":"12","author":"Zhong","year":"2021","journal-title":"Nat Commun"},{"issue":"9","key":"2024061013552579200_bib26","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1016\/j.jtha.2023.05.016","article-title":"Limited concordance of heparin\/platelet factor 4 antibody assays for the diagnosis of heparin-induced thrombocytopenia: an analysis of the TORADI-HIT study","volume":"21","author":"Hammerer-Lercher","year":"2023","journal-title":"J\u00a0Thromb Haemost"},{"key":"2024061013552579200_bib27","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.thromres.2021.04.017","article-title":"Accuracy of the functional, flow cytometer-based emo-test HIT confirm for the diagnosis of heparin-induced thrombocytopenia","volume":"203","author":"Brodard","year":"2021","journal-title":"Thromb Res"},{"issue":"22","key":"2024061013552579200_bib28","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1182\/bloodadvances.2018024489","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia","volume":"2","author":"Cuker","year":"2018","journal-title":"Blood Adv"},{"issue":"5","key":"2024061013552579200_bib29","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/bjh.12059","article-title":"Guidelines on the diagnosis and management of heparin-induced thrombocytopenia: second edition","volume":"159","author":"Watson","year":"2012","journal-title":"Br J Haematol"},{"issue":"6","key":"2024061013552579200_bib30","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1055\/s-0038-1646493","article-title":"A\u00a0rapid and sensitive test for diagnosing heparin-associated thrombocytopenia","volume":"66","author":"Greinacher","year":"1991","journal-title":"Thromb Haemost"},{"key":"2024061013552579200_bib31","unstructured":"Olink. Data normalization and standardization (white paper v2.0). 2021:1-8. Accessed 4 March 2024. https:\/\/olink.com\/content\/uploads\/2021\/09\/olink-data-normalization-white-paper-v2.0.pdf."},{"issue":"1","key":"2024061013552579200_bib32","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1038\/s41467-023-38383-y","article-title":"Elevated plasma complement factor H related 5 protein is associated with venous thromboembolism","volume":"14","author":"Iglesias","year":"2023","journal-title":"Nat Commun"},{"issue":"6220","key":"2024061013552579200_bib33","doi-asserted-by":"crossref","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"issue":"9","key":"2024061013552579200_bib34","doi-asserted-by":"crossref","first-page":"e106239","DOI":"10.1371\/journal.pone.0106239","article-title":"Role of Siglec-7 in apoptosis in human platelets","volume":"9","author":"Nguyen","year":"2014","journal-title":"PLoS One"},{"issue":"Suppl 1","key":"2024061013552579200_bib35","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1182\/blood-2020-139651","article-title":"Genome-wide association study identifies variation in ABO as risk factor for platelet reactivity in heparin-induced thrombocytopenia","volume":"136","author":"Giles","year":"2020","journal-title":"Blood"},{"issue":"8","key":"2024061013552579200_bib36","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00109-018-1661-6","article-title":"Targeted resequencing of a locus for heparin-induced thrombocytopenia on chromosome 5 identified in a genome-wide association study","volume":"96","author":"Witten","year":"2018","journal-title":"J\u00a0Mol Med"},{"issue":"4","key":"2024061013552579200_bib37","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1160\/TH14-08-0670","article-title":"A\u00a0genome-wide association study of heparin-induced thrombocytopenia using an electronic medical record","volume":"113","author":"Karnes","year":"2015","journal-title":"Thromb Haemost"},{"issue":"16","key":"2024061013552579200_bib38","doi-asserted-by":"crossref","first-page":"10058","DOI":"10.1074\/jbc.273.16.10058","article-title":"Comparison of promoters for the murine and human P-selectin genes suggests species-specific and conserved mechanisms for transcriptional regulation in endothelial cells","volume":"273","author":"Pan","year":"1998","journal-title":"J\u00a0Biol Chem"},{"issue":"10","key":"2024061013552579200_bib39","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1182\/blood.V95.10.3146","article-title":"Interleukin-13 induces PSGL-1\/P\u2013selectin\u2013dependent adhesion of eosinophils, but not neutrophils, to human umbilical vein endothelial cells under flow","volume":"95","author":"Woltmann","year":"2000","journal-title":"Blood"},{"key":"2024061013552579200_bib40","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.thromres.2019.05.016","article-title":"Evaluation of a flow cytometer-based functional assay using platelet-rich plasma in the diagnosis of heparin-induced thrombocytopenia","volume":"180","author":"Althaus","year":"2019","journal-title":"Thromb Res"},{"issue":"2","key":"2024061013552579200_bib41","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1182\/blood-2017-02-770479","article-title":"Circulating soluble P-selectin must dimerize to promote inflammation and coagulation in mice","volume":"130","author":"Panicker","year":"2017","journal-title":"Blood"},{"issue":"24","key":"2024061013552579200_bib42","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/j.ehj.2003.08.021","article-title":"The adhesion molecule P-selectin and cardiovascular disease","volume":"24","author":"Blann","year":"2003","journal-title":"Eur Heart J"},{"issue":"3","key":"2024061013552579200_bib43","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1161\/ATVBAHA.108.182188","article-title":"Biomarkers and venous thromboembolism","volume":"29","author":"Pabinger","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"2024061013552579200_bib44","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1177\/1076029611405032","article-title":"Evaluation of soluble P-selectin as a marker for the diagnosis of deep venous thrombosis","volume":"17","author":"Ramacciotti","year":"2011","journal-title":"Clin Appl Thromb Hemost"},{"issue":"12","key":"2024061013552579200_bib45","doi-asserted-by":"crossref","first-page":"E468","DOI":"10.1002\/ajh.26372","article-title":"Plasma P-selectin is an early marker of thromboembolism in COVID -19","volume":"96","author":"Fenyves","year":"2021","journal-title":"Am J Hematol"},{"issue":"6","key":"2024061013552579200_bib46","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1055\/s-0038-1650710","article-title":"Soluble P-selectin as parameter for platelet activation during storage","volume":"76","author":"Kostelijk","year":"1996","journal-title":"Thromb Haemost"},{"issue":"6","key":"2024061013552579200_bib47","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1182\/blood.V83.6.1535.1535","article-title":"Plasma P-selectin is increased in thrombotic consumptive platelet disorders","volume":"83","author":"Chong","year":"1994","journal-title":"Blood"},{"issue":"suppl 1","key":"2024061013552579200_bib48","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1177\/10760296990050S108","article-title":"Soluble adhesion molecules in the HIT syndrome: pathophysiologic role and therapeutic modulation","volume":"5","author":"Fareed","year":"1999","journal-title":"Clin Appl Thromb Hemost"},{"issue":"2","key":"2024061013552579200_bib49","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/107602960000600204","article-title":"Soluble P-selectin in human plasma: effect of anticoagulant matrix and its levels in patients with cardiovascular disorders","volume":"6","author":"Amin","year":"2000","journal-title":"Clin Appl Thromb Hemost"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/11\/2825\/2228412\/blooda_adv-2024-012782-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/11\/2825\/2228412\/blooda_adv-2024-012782-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T13:56:07Z","timestamp":1718027767000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/8\/11\/2825\/515662\/Proteomic-profiling-for-biomarker-discovery-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,31]]},"references-count":49,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,6,11]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2024012782","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,31]]}}}